Fundz

Virometix Announces Successful Closing of Series B Investment Round raising CHF 7.5 million

PRIVATEJul 16, 2020

Amount Raised

$5 Million

Round Type

Series B

SchlierenBiotechnology

Description

Virometix, a privately held Swiss biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and oncology diseases, announced today that it has successfully completed a CHF 7.5 million Series B equity financing round.

Quick answer

Virometix AG raised $5 Million in a Series B round, dated July 16, 2020. Virometix AG is based in Schlieren, Zurich, Switzerland.

How much did Virometix AG raise?
Virometix AG raised $5 Million in a Series B round on July 16, 2020.
What does Virometix AG do?
Virometix is a privately held Swiss biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and oncology diseases
Where is Virometix AG based and how big is it?
Virometix AG is based in Schlieren, Zurich, Switzerland.
Who are the decision-makers at Virometix AG?
Fundz holds 1 contact at Virometix AG. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Virometix AG that raised within 45 days of this round, from Fundz verified event records.

  • Prelude Therapeutics Inc raised $50M on August 28, 2020.
  • BirchBioMed Inc. raised $399K (Seed) on August 28, 2020.
  • Optimize Systems raised $15M on August 28, 2020.
  • Retrotope, Inc. raised $10M on August 28, 2020.
  • Genemod Corp raised $1M (Seed) on August 28, 2020.
  • Nanotech Energy, Inc. raised $28M on August 28, 2020.

Who to call at Virometix AG, and when

A new round usually means Virometix AG is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Virometix AG raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Virometix AG, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Virometix AG. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Virometix AG

Location

Schlieren, Zurich, Switzerland

About

Virometix is a privately held Swiss biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and oncology diseases

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Virometix AG raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Virometix AG's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Virometix AG raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.